These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 31928530)
1. Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progression. Yuan K; Ye J; Liu Z; Ren Y; He W; Xu J; He Y; Yuan Y J Exp Clin Cancer Res; 2020 Jan; 39(1):9. PubMed ID: 31928530 [TBL] [Abstract][Full Text] [Related]
2. DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression. Li X; Na H; Xu L; Zhang X; Feng Z; Zhou X; Cui J; Zhang J; Lin F; Yang S; Yue F; Mousa H; Zuo Y Biomed Pharmacother; 2020 Jan; 121():109644. PubMed ID: 31766099 [TBL] [Abstract][Full Text] [Related]
3. STAM2 knockdown inhibits proliferation, migration, and invasion by affecting the JAK2/STAT3 signaling pathway in gastric cancer. Yang Y; Zhang Q; Liang J; Yang M; Wang Z; Tang D; Wang D Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):697-706. PubMed ID: 33778841 [TBL] [Abstract][Full Text] [Related]
4. STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer. Pan YM; Wang CG; Zhu M; Xing R; Cui JT; Li WM; Yu DD; Wang SB; Zhu W; Ye YJ; Wu Y; Wang S; Lu YY Mol Cancer; 2016 Dec; 15(1):79. PubMed ID: 27938379 [TBL] [Abstract][Full Text] [Related]
5. SIRT6 inhibits growth of gastric cancer by inhibiting JAK2/STAT3 pathway. Zhou J; Wu A; Yu X; Zhu J; Dai H Oncol Rep; 2017 Aug; 38(2):1059-1066. PubMed ID: 28656307 [TBL] [Abstract][Full Text] [Related]
6. Mitochondrial ROS accumulation inhibiting JAK2/STAT3 pathway is a critical modulator of CYT997-induced autophagy and apoptosis in gastric cancer. Cao Y; Wang J; Tian H; Fu GH J Exp Clin Cancer Res; 2020 Jun; 39(1):119. PubMed ID: 32576206 [TBL] [Abstract][Full Text] [Related]
7. Correlation of IL-6 and JAK2/STAT3 signaling pathway with prognosis of nasopharyngeal carcinoma patients. Zhuang M; Ding X; Song W; Chen H; Guan H; Yu Y; Zhang Z; Dong X Aging (Albany NY); 2021 Jun; 13(12):16667-16683. PubMed ID: 34165442 [TBL] [Abstract][Full Text] [Related]
8. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance. Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278 [TBL] [Abstract][Full Text] [Related]
9. Ceramide synthase 6 predicts the prognosis of human gastric cancer: It functions as an oncoprotein by dysregulating the SOCS2/JAK2/STAT3 pathway. Uen YH; Fang CL; Lin CC; Hseu YC; Hung ST; Sun DP; Lin KY Mol Carcinog; 2018 Dec; 57(12):1675-1689. PubMed ID: 30129684 [TBL] [Abstract][Full Text] [Related]
10. Intracellular matrix Gla protein promotes tumor progression by activating JAK2/STAT5 signaling in gastric cancer. Wang M; Chen L; Chen Y; Wei R; Guo Q; Zhu S; Guo S; Zhu S; Zhang S; Min L Mol Oncol; 2020 May; 14(5):1045-1058. PubMed ID: 32086862 [TBL] [Abstract][Full Text] [Related]
11. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy. Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543 [TBL] [Abstract][Full Text] [Related]
12. Basic Transcription Factor 3 Is Required for Proliferation and Epithelial-Mesenchymal Transition via Regulation of FOXM1 and JAK2/STAT3 Signaling in Gastric Cancer. Zhang DZ; Chen BH; Zhang LF; Cheng MK; Fang XJ; Wu XJ Oncol Res; 2017 Nov; 25(9):1453-1462. PubMed ID: 28276310 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA LINC00165-induced by STAT3 exerts oncogenic properties via interaction with Polycomb Repressive Complex 2 to promote EMT in gastric cancer. Jin Y; Wu P; Zhao W; Wang X; Yang J; Huo X; Chen J; De W; Yang F Biochem Biophys Res Commun; 2018 Dec; 507(1-4):223-230. PubMed ID: 30448060 [TBL] [Abstract][Full Text] [Related]
14. Human epidermal growth factor receptor 2 expressions and Janus-activated kinase/signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway may be associated with clinicopathological features and prognosis of gastric cancer. Xu W; Fu J; Wu H; Sun W J Cancer Res Ther; 2018 Jun; 14(Supplement):S311-S318. PubMed ID: 29970682 [TBL] [Abstract][Full Text] [Related]
15. [Gastric cancer-derived mesenchymal stem cells regulate the M2 polarization of macrophages within gastric cancer microenvironment via JAK2/STAT3 signaling pathway]. Li W; Zhao SL; Zheng P; Shi PQ; Zhou Y; Zhang T; Huo J; Yang J Zhonghua Zhong Liu Za Zhi; 2022 Jul; 44(7):728-736. PubMed ID: 35880339 [No Abstract] [Full Text] [Related]
16. Downregulation of Piwil3 suppresses cell proliferation, migration and invasion in gastric cancer. Jiang L; Wang WJ; Li ZW; Wang XZ Cancer Biomark; 2017 Dec; 20(4):499-509. PubMed ID: 28869440 [TBL] [Abstract][Full Text] [Related]
17. IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway. Wu X; Tao P; Zhou Q; Li J; Yu Z; Wang X; Li J; Li C; Yan M; Zhu Z; Liu B; Su L Oncotarget; 2017 Mar; 8(13):20741-20750. PubMed ID: 28186964 [TBL] [Abstract][Full Text] [Related]
18. RBMS1 promotes gastric cancer metastasis through autocrine IL-6/JAK2/STAT3 signaling. Liu M; Li H; Zhang H; Zhou H; Jiao T; Feng M; Na F; Sun M; Zhao M; Xue L; Xu L Cell Death Dis; 2022 Mar; 13(3):287. PubMed ID: 35361764 [TBL] [Abstract][Full Text] [Related]
19. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway. Zheng L; Chen J; Zhou Z; He Z Tumour Biol; 2017 May; 39(5):1010428317705335. PubMed ID: 28475004 [TBL] [Abstract][Full Text] [Related]
20. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer. Wei ZW; Xia GK; Wu Y; Chen W; Xiang Z; Schwarz RE; Brekken RA; Awasthi N; He YL; Zhang CH Cancer Lett; 2015 Apr; 359(2):335-43. PubMed ID: 25641338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]